C

CaaS Capital Management

18 employees

CaaS Capital Management is investing across all regions, industries, and capital structures.

Investor insights

Sectors invested in

Biotechnology6
Biopharma4
Information Technology2
Health Care2
Therapeutics2
cancer testis antigens1
Pharmaceutical1
Developer Platform1
Life Science1
TCR characterization1
target selection1
neoantigens1
neoepitopes1
AAV Vectors1
Gene Therapy1
gene therapy1
TCR generation1
adoptive T cell therapy1
immunoncology1
retroviral vectors1

Funding rounds participated in

$100M sweet spot round size

Most of their 7 investments are in rounds between $80M and $110M

Investor type

Venture Capital

Basic info

Industry

financial services

Sectors

Financial Services

Date founded

2019

Investments made

U

Undisclosed raised $75M on September 30, 2022

Investors: Laurion Capital Management LP, Perceptive Advisors, RA Capital Management, L.P., The Invus Group, Pura Vida Investments and CaaS Capital Management

V

Ventyx Biosciences raised $177M on September 19, 2022

Investors: Great Point Partners, Walleye Capital, Logos Global Management, LP, Woodline Partners LP, Vivo Capital, Redmile Group, Driehaus Capital Management LLC and CaaS Capital Management

H

HotSpot Therapeutics, Inc. raised $100M on November 29, 2021

Investors: S.R. One Ltd, Monashee Investment Management LLC, Sofinnova Partners, Revelation Partners, B Capital Group, Atlas Venture, LSP (Life Sciences Partners) and CaaS Capital Management

T

T-knife Therapeutics raised $110M on August 2, 2021

Investors: Andera Partners, Qatar Investment Authority, Sixty Degree Capital, EQT Life Sciences, Casdin Capital, LLC, Versant Ventures, RA Capital Management, L.P. and CaaS Capital Management

U

Umoja Biopharma raised $210M on June 15, 2021

Investors: Presight Capital, SVB Securities, SoftBank Investment Advisers, Temasek, RTW Investments, LP and CaaS Capital Management

S

StrideBio, Inc raised $82M on March 16, 2021

Investors: UCB Ventures, Octagon Capital Advisors, Northpond Ventures, UF Innovate | Ventures, Novo Holdings, Takeda UK Limited, Pontifax Venture Capital, Sarepta Therapeutics and CaaS Capital Management

C

Cyteir Therapeutics raised $80M on February 11, 2021

Investors: Avidity Partners, Venrock, Osage University Partners (OUP), Novo Holdings, Lightstone Ventures, RA Capital Management, L.P. and CaaS Capital Management

FAQ